The Cigna Group (NYSE:CI) Stock Position Raised by Pine Valley Investments Ltd Liability Co

Pine Valley Investments Ltd Liability Co increased its holdings in shares of The Cigna Group (NYSE:CIFree Report) by 10.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,366 shares of the health services provider’s stock after acquiring an additional 1,653 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in The Cigna Group were worth $4,796,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Swedbank AB increased its holdings in shares of The Cigna Group by 55.1% during the fourth quarter. Swedbank AB now owns 884,406 shares of the health services provider’s stock valued at $244,220,000 after purchasing an additional 314,123 shares during the period. FMR LLC grew its position in The Cigna Group by 2.0% in the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock valued at $4,929,978,000 after buying an additional 279,880 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in The Cigna Group by 68.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock valued at $137,483,000 after buying an additional 202,161 shares during the period. World Investment Advisors LLC bought a new stake in The Cigna Group during the third quarter worth approximately $69,972,000. Finally, Two Sigma Advisers LP lifted its holdings in shares of The Cigna Group by 995.9% in the third quarter. Two Sigma Advisers LP now owns 215,900 shares of the health services provider’s stock valued at $74,796,000 after buying an additional 196,200 shares during the period. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.3 %

Shares of CI stock opened at $300.80 on Tuesday. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a market cap of $83.67 billion, a price-to-earnings ratio of 24.58, a PEG ratio of 0.98 and a beta of 0.54. The stock has a 50-day moving average of $286.90 and a 200-day moving average of $319.23.

The Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the company posted $6.79 EPS. On average, equities research analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 2.01%. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio is 49.35%.

Analyst Ratings Changes

Several equities research analysts have recently commented on CI shares. UBS Group reduced their target price on The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Barclays lowered their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Cantor Fitzgerald lowered their target price on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Finally, Stephens dropped their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $372.31.

View Our Latest Report on CI

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.